Work

Abstract CT127: First-in-human study of ES014, a bispecific antibody targeting CD39 and TGF-β as monotherapy in patients with advanced solid tumors

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct127

Authors: Sai Ge, Tong Xie, Jian Li, Yehua Zhu, Di Luo, Quan Qiu, Bin Chen, Jiayu Song, Hongtao Lu, Lin Shen

Institution: Peking University Cancer Hospital

Language: English

Topic: Adenosine and Purinergic Signaling

Subfield: Physiology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154748901

Cites:

Cited by:

Related to: